Endo Applies for FDA Approval of Film Strip Opioid, Claims fewer Side Effects

Endo Pharmaceuticals, a prominent painkiller manufacturer, has submitted an application to the Food and Drug Administration for a new opioid analgesic it says has fewer side effects than similar medications. Endo submitted the application along with BioDelivery Sciences, according to a Dec. 23 press release. The drug, buprenorphine hydrochloride buccal, would be administered via a strip of film the patient would place inside his or her cheek. The companies conducted two double-blind, randomized, placebo-controlled, enriched enrollment studies to gauge the effectiveness and safe...